OptigoBio

Watch the video to learn more about #OptigoBio #LifetimeBetterVision @OptigoBio is grateful Brian Calvert of biofilm MEDIA, @GrowthCat_ab, @LifeSciences_BC and @PacifiCanEN, for their dedication and support that have made the video production possible.

Watch the video to learn more about #OptigoBio #LifetimeBetterVision @OptigoBio is grateful Brian Calvert of biofilm MEDIA, @GrowthCat_ab, @LifeSciences_BC and @PacifiCanEN, for their dedication and support that have made the video production possible.

We are moving toward clinical trials to bring this approach closer to patients. #biotech #biotherapeutics #innovation #ophthalmology #retina #visionresearch

The logo of @OptigoBio reflects our goal: reducing the burden of monthly eye injections on patients, physicians, and payers. Our latest data shows that Optigo's platform could significantly extend the half life of current and future intravitreal treatments for #retinaldiseases.

We look forward to reconnecting with colleagues & industry peers in Zürich at #Sachs_ELSF, part of #SSLSW. We're pleased to share updates from @OptigoBio and would welcome the opportunity to connect. Please contact us: info@optigobio.com #OptigoBio #LifetimeBetterVision

The @OptigoBio team is pleased to attend the #Sachs_ELSF, a part of #SSLSW, organized by @SachsAssociates. More information: sachsforum.com/19elsf-about.h… #innovation #investment #lifesciences Learn more about #OurVision: optigobio.com #OptigoBio #LifetimeBetterVision

Explore what’s next in life sciences at Access to Innovation 2026 — a day of insights and connections. Introducing the GSK Panel: Breaking Barriers in Clinical Research. Bryan Tennant, Lakshmi Krishnan, Stephania Manusha & Dr. Geoff Payne Register here: lifesciencesbc.ca/event/11th-ann…

Optigo Biotherapeutics team is delighted to attend the @JPMorgan #JPMHC2026 To connect, contact us: info@optigobio.com To learn more about #OurVision, visit our website: optigobio.com #OptigoBio #LifetimeBetterVision #JPM2026 #JPM26 #biotherapeutics #innovation

As we look toward 2026, we remain focused on innovation and delivering lasting value for ophthalmology patients. We wish you a pleasant holiday season and look forward to continued growth in the year ahead. Ali Ardakani Co-Founder & CEO Optigo Biotherapeutics Inc. (@OptigoBio)

Ali Ardakani, Co-Founder & CEO @OptigoBio, looks forward to speaking at the McCarthy Spotlight Speaking Series, led by @LifeSciences_BC Speakers: - Ali Ardakani - Louis-Philippe Bernier - Mike Dolphin - Jackie Labbe - Amir Vohooshi Event information: lifesciencesbc.ca/event/mccarthy…

Join us at the McCarthy Spotlight Speaking Series, led by LSBC. Date: Nov. 27, 2025 Time: 4:30 pm – 7:00 pm Location: McCarthy Tétrault Office Speakers: - Amir Vohooshi - Louis-Philippe Bernier - Mike Dolphin - Ali Ardakani - Jackie Labbe Learn more: lifesciencesbc.ca/event/mccarthy…

The @OptigoBio team looks forward to connecting with #healthcare industry executives & leaders during the @Jefferies Global Healthcare Conference in London, held Nov 17–20, 2025 jefferies.com/events/global-… #biotech #healthcare #pharma #therapeutics #OptigoBio #LifetimeBetterVision

@OptigoBio: Lead anti-VEGF program advancing toward IND-enabling studies by: David S. Boyer, MD; Arshad M. Khanani, MD, MA, FASRS; Sheryl Stevenson ophthalmologytimes.com/view/optigo-le… #biotherapeutics #innovation #ophthalmology #visionresearch #OptigoBio #LifetimeBetterVision

Q&A: Advancing a long-acting anti-VEGF candidate: What it means for retinal disease by: Harpal Sandhu, MD, FRCSC; Sheryl Stevenson ophthalmologytimes.com/view/q-a-advan… #biotherapeutics #innovation #ophthalmology #visionresearch #OptigoBio #LifetimeBetterVision

Optigo Biotherapeutics (@OptigoBio) names Andreas Wallnöfer, PhD, MBA, to board as lead retinal program advances Read more: ophthalmologytimes.com/view/optigo-bi… #biotherapeutics #innovation #ophthalmology #visionresearch #OptigoBio #LifetimeBetterVision

Earlier this year, @optigobio won the People's Choice Award at Eyecelerator @ ARVO 2025. Now they are welcoming Dr. Andreas Wallnöfer to their Board of Directors as they advance to IND-Enabling Studies. Read their press release here: optigobio.com/press-release-…

Renowned Pharma & Biotech Development Leader Dr. Andreas Wallnoefer named to @OptigoBio’s Board as the company advances to IND-enabling studies Press Release: globenewswire.com/news-release/2… #biotherapeutics #innovation #ophthalmology #visionresearch #OptigoBio #LifetimeBetterVision

Huge thanks to all sponsors and event supporters: @InnovateBC @AbCelleraBio @AcuitasTx @AspectBiosys @Cytiva @Evonik @GenomeBC @JNJInnovMed @STEMCELLTech @helpStPauls @VGHFdn @CastlCanada @BFLCANADA @FarrisLLP @StemCellNetwork

Companies to Watch - #Recognition #Honour Roll: (* Note: not a competitive award category but a recognition of emerging companies demonstrating significant potential within the BC life sciences) · AVEE HEALTH · @CereCura · GuideStar Medical Devices · @OptigoBio · @PhytonBiotech

On October 2, 2025, we had the honour to attend an incredible event 🏆 #LSBCAwards organized by @LifeSciences_BC: a true celebration of #leadership, #innovation, and #impact.